Mr. James Stephen Stone, M.S., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 135 Mass. Ave, Arlington, MA 02474 Phone: 781-646-2040 Fax: 781-646-2223 |
News Archive
The genetic and molecular make-up of individual breast tumors holds clues to how a woman's disease could progress, including the likelihood of it coming back after treatment, and in what time frame, according to a Cancer Research UK-funded study published in Nature today (Wednesday).
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, granted 745,000 options to certain officers of the Company pursuant to the Company's employee stock option plan. Each option under the Plan is exercisable to acquire one common share at a price of $0.28 per option.
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that it received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) on the new drug application (NDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for relapsing-remitting multiple sclerosis (MS).
Soon you may no longer have to worry about how long your dental repairs will last. A new dental reconstruction material developed in Sweden offers unprecedented improvements over existing acrylate-based fillers.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and The Regents of the University of California, Los Angeles campus, today announced the execution of an exclusive research agreement that will focus on the identification of biological markers of mucosal healing in patients with Inflammatory Bowel Disease (IBD). The research will be led by Dr. Jonathan Braun, Chair of the Department of Pathology and Laboratory Medicine and a professor of molecular and medical pharmacology, UCLA David Geffen School of Medicine.
› Verified 2 days ago